Strategic partnership Access Vascular recently announced a multi-year cobranded partnership with Medline Industries to launch next-generation vascular access catheters, signaling a dual-channel sales opportunity through Medline’s distribution network and hospital systems.

Co branded products The launch of cobranded HydroPICC and HydroMID catheters presents a collaboration angle for sales teams to approach customers via joint branding, leveraging Medline’s existing relationships to accelerate adoption in clinical settings.

Expansion momentum Frequent press coverage of new product launches and data presentations at industry events (INS 2025, AVA 2024) indicates growing market visibility and ongoing clinical validation, creating doors for expansion into hospitals prioritizing vascular access innovation.

Leadership engagements New senior hires including a National Sales Director and a Board member reflect a strengthened go-to-market strategy and governance, signaling readiness for larger account visits, tender responses, and enterprise opportunities.

Clinical value The company focuses on reducing infection, thrombosis, and phlebitis with hydrophilic catheter technology and outcome-focused messaging, aligning well with value-based procurement programs and Capstone Health Alliance-style collaborations that emphasize clinical outcomes.